UBS Group’s Alzamend Neuro ALZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63K | Buy |
+902
| New | +$2.63K | ﹤0.01% | 8113 |
|
|
2025
Q1 | – | Sell |
-91
| Closed | -$951 | – | 8861 |
|
|
2024
Q4 | $951 | Buy |
+91
| New | +$951 | ﹤0.01% | 8096 |
|
|
2024
Q3 | – | Sell |
-57
| Closed | -$2.02K | – | 8240 |
|
|
2024
Q2 | $2.02K | Buy |
+57
| New | +$2.02K | ﹤0.01% | 7274 |
|
|
2024
Q1 | – | Sell |
-21
| Closed | -$1.7K | – | 8067 |
|
|
2023
Q4 | $1.7K | Buy |
21
+15
| +250% | +$1.21K | ﹤0.01% | 7026 |
|
|
2023
Q3 | $1.88K | Buy |
+6
| New | +$1.88K | ﹤0.01% | 6662 |
|
|
2023
Q2 | – | Sell |
-2
| Closed | -$1.26K | – | 7377 |
|
|
2023
Q1 | $1.26K | Sell |
2
-5
| -71% | -$3.16K | ﹤0.01% | 7673 |
|
|
2022
Q4 | $5.22K | Sell |
7
-7
| -50% | -$5.22K | ﹤0.01% | 8009 |
|
|
2022
Q3 | $22K | Sell |
14
-1
| -7% | -$1.57K | ﹤0.01% | 6146 |
|
|
2022
Q2 | $18K | Buy |
15
+3
| +25% | +$3.6K | ﹤0.01% | 5949 |
|
|
2022
Q1 | $20K | Buy |
12
+10
| +500% | +$16.7K | ﹤0.01% | 6394 |
|
|
2021
Q4 | $5K | Hold |
2
| – | – | ﹤0.01% | 8245 |
|
|
2021
Q3 | $8K | Hold |
2
| – | – | ﹤0.01% | 7037 |
|
|
2021
Q2 | $24K | Buy |
+2
| New | +$24K | ﹤0.01% | 6042 |
|